Rating History for Flexion Therapeutics (FLXN) by Northland
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/19/2021 | Carl Byrnes | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
9.12 (25.27) |
177.08% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||


